Triglycerides — Natural Management of Blood Fat
How sugar and refined carbs raise blood triglycerides, what foods and habits bring them down, and what the evidence says about omega-3, niacin, berberine, and exercise
Triglycerides are the form your body uses to store and transport fat in the blood. A little is normal and necessary. A lot — what doctors call hypertriglyceridemia — is one of the strongest signals that something is off with the way your body handles sugar and refined carbohydrates. [2] Unlike LDL cholesterol, which is mostly driven by saturated fat and genetics, triglycerides respond rapidly to what you eat and how you move. Cut the sugar and refined flour, add omega-3-rich fish, walk every day, and most people see numbers fall within weeks. [2] [4]
What Triglycerides Are and Why They Matter
When you eat more carbohydrate or fat than your body needs in the moment, the liver packages the surplus into triglyceride molecules and ships them out in particles called VLDL (very-low-density lipoprotein). Some of that fat gets used by muscle for energy; the rest is stored. A blood test taken after an overnight fast measures what's still circulating, and the number reflects both how much fat you ate and — more importantly — how efficiently your liver is clearing sugar. [2]
Standard reference ranges:
- Optimal: under 100 mg/dL (1.13 mmol/L)
- Normal: under 150 mg/dL (1.7 mmol/L)
- Borderline-high: 150–199 mg/dL
- High: 200–499 mg/dL
- Very high: 500 mg/dL or more — this is where pancreatitis risk climbs sharply
High triglycerides almost always travel with low HDL cholesterol, small dense LDL particles, and rising blood sugar — the cluster called metabolic syndrome. See our Metabolic Syndrome page and Insulin Resistance page for the broader picture, because triglycerides rarely move alone.
Why "Sugar Raises Triglycerides" Is the Headline
This is the single most important thing to understand about triglycerides: in a metabolically healthy person, dietary fat is digested, absorbed, and largely cleared. Dietary sugar — especially fructose from sugar-sweetened beverages and high-fructose corn syrup — is routed to the liver, where excess gets converted directly into new triglycerides through a process called de novo lipogenesis. A 10-week trial that swapped 25% of daily calories for fructose-sweetened beverages produced significant rises in fasting and post-meal triglycerides, while the same calories from glucose did not. [3] If your triglycerides are high, the first lever to pull is sugary drinks, sweets, and refined-flour foods — not the eggs, olive oil, or nuts on your plate.
What Actually Lowers Triglycerides
1. Cut Liquid Sugar and Refined Carbs
Sugar-sweetened beverages, fruit juices, sweetened coffee drinks, and white-flour foods (bread, pastries, cereals, crackers) are the top dietary drivers of high triglycerides. [2] [3] Whole fruit is fine — the fiber slows absorption and the dose of fructose per serving is far lower than juice or soda. The fastest practical wins:
- Replace soda and juice with water, sparkling water, or unsweetened tea
- Replace breakfast cereal and toast with eggs, full-fat plain yogurt, or oatmeal
- Treat dessert as something you eat occasionally, not daily
2. Eat the Mediterranean Pattern
The PREDIMED trial — the largest randomized diet study ever conducted — assigned 7,447 high-risk adults to either a Mediterranean diet supplemented with extra-virgin olive oil, the same diet supplemented with mixed nuts, or a low-fat control diet. Over roughly five years, both Mediterranean groups had a ~30% lower rate of major cardiovascular events compared with the low-fat group, alongside better lipid profiles including lower triglycerides. [4] The pattern is generous in olive oil, fish, vegetables, legumes, nuts, and whole grains; modest in poultry and fermented dairy; and low in sweets, refined grains, and processed meat.
3. Use Omega-3 Fatty Acids — At the Right Dose
This is where supplements actually have strong evidence. The American Heart Association's 2019 advisory concluded that prescription omega-3s (EPA alone or EPA + DHA) at 4 grams per day reduce triglycerides by 20–30% and are "an effective and safe option" for people with triglycerides ≥200 mg/dL. [2] At the standard 1-gram fish oil capsule sold in pharmacies, you would need four capsules a day to hit that dose, and only about 30–35% of each capsule is actually EPA + DHA — so most over-the-counter doses are too low to move triglycerides much.
The REDUCE-IT trial took this further. It randomized 8,179 statin-treated patients with triglycerides 135–500 mg/dL to 4 g/day of icosapent ethyl (a purified prescription EPA) or placebo, and found a 25% relative reduction in major cardiovascular events over five years. [1] The earlier JELIS trial in 18,645 Japanese patients had already shown that 1.8 g/day of EPA on top of a statin cut major coronary events by 19%. [5] Together they make EPA the best-evidenced supplement for both lowering triglycerides and reducing cardiovascular events. See our Omega-3 page for sourcing and dosing details.
A practical caveat: a separate trial (STRENGTH) of a different EPA + DHA formulation did not show event reduction, so the EPA-only data are stronger than the mixed formulations. Most people should aim for at least 2–3 g/day of combined EPA + DHA from oily fish (sardines, salmon, mackerel, herring, anchovies) two or three times a week, and consider higher-dose supplementation if their triglycerides remain elevated. See our Sardines page and Wild Salmon page for whole-food sources.
4. Move Daily — Even Without Weight Loss
A 2025 meta-analysis pooling 148 randomized exercise trials in over 8,600 adults found that exercise training reduced triglycerides by about 8 mg/dL on average, and the benefit appeared across aerobic, resistance, and combined modalities. [8] The drop was modest in absolute terms but came on top of any weight-loss effects and was achieved with realistic doses (most studies used 30–50 minutes, three to five times per week). Exercise also raises HDL and improves insulin sensitivity, both of which feed back into lower triglycerides. See our Walking page, Zone 2 Cardio page, and Resistance Training page.
5. Consider Berberine
Berberine — an alkaloid found in goldenseal, barberry, and Oregon grape root — has consistent meta-analytic evidence as a triglyceride-lowering supplement. A 2013 systematic review of 11 randomized trials in 874 participants found berberine reduced triglycerides by an average of 0.50 mmol/L (about 44 mg/dL), with parallel improvements in total and LDL cholesterol. [7] The standard dose used in trials is 500 mg taken two or three times daily with meals. Berberine works by activating AMP-activated protein kinase (AMPK) — the same target metformin hits — and is one of the few non-prescription options with both lipid and glucose benefits. See our Berberine page for full details.
6. Niacin: A Cautionary Note
Niacin (vitamin B3 in pharmacologic doses, typically 1–2 g/day extended-release) reliably raises HDL and lowers triglycerides, but the AIM-HIGH trial — which added extended-release niacin to statin therapy in 3,414 high-risk patients — was stopped early because it produced no reduction in cardiovascular events despite favorable changes in cholesterol numbers. [6] The follow-up HPS2-THRIVE trial in 25,000 patients showed similar lack of benefit and added safety concerns including bleeding and infection risk. The lesson: improving the number on the lab report does not automatically improve outcomes, and niacin in high-dose pharmaceutical form is no longer routinely recommended for cardiovascular prevention. Food-level niacin from poultry, fish, peanuts, and whole grains is fine and unproblematic. See our Niacin page for the wider picture.
7. Address Alcohol
Alcohol is metabolized by the liver into acetate, which the liver can readily convert to fatty acids and triglycerides. People with already-elevated triglycerides (especially above 500 mg/dL) often see large drops simply by cutting alcohol entirely for a few weeks. The AHA advisory specifically recommends limiting alcohol in anyone with elevated triglycerides. [2]
When to Think About Medication
Lifestyle changes can take triglycerides from 300 down to 150 mg/dL within a few months for most people willing to overhaul sugar intake and add fish or omega-3 supplements. But triglycerides above 500 mg/dL, and especially above 1,000 mg/dL, carry meaningful risk of pancreatitis and warrant a conversation with a clinician about prescription options (icosapent ethyl, fibrates) alongside the lifestyle work. [2] The natural-first approach is not the natural-only approach.
Evidence Review
The Sugar–Triglyceride Link: Stanhope 2009
Stanhope and colleagues conducted what remains one of the cleanest controlled feeding studies on sugar and lipids. [3] In a 10-week parallel-arm design, 32 overweight or obese adults consumed beverages providing 25% of their daily energy as either glucose or fructose while eating an otherwise comparable diet. Both groups gained similar weight, but the fructose group developed significantly increased visceral adipose tissue, elevated 24-hour triglyceride concentrations, increased small dense LDL particles, and reduced insulin sensitivity. The glucose group showed none of these effects. The study established two principles that recur in every subsequent trial: liquid fructose specifically (more than glucose, more than solid sugar) drives triglyceride synthesis in the liver, and weight gain alone does not explain lipid worsening — the macronutrient identity matters.
The Mediterranean Pattern: PREDIMED 2018
The PREDIMED (Prevención con Dieta Mediterránea) trial randomized 7,447 high-cardiovascular-risk adults in Spain to one of three diets for a median 4.8 years: Mediterranean diet plus 1 liter/week of extra-virgin olive oil, Mediterranean diet plus 30 g/day of mixed nuts, or a low-fat control. [4] The original 2013 publication was retracted and reanalyzed for randomization issues; the corrected 2018 analysis confirmed that the two Mediterranean groups had hazard ratios of approximately 0.69 for the composite primary endpoint of myocardial infarction, stroke, or cardiovascular death. Triglycerides decreased modestly in the Mediterranean groups versus control. The trial is not a head-to-head Mediterranean-vs-low-carb comparison, but it remains the strongest evidence that a high-fat plant-based eating pattern reduces hard cardiovascular outcomes.
Prescription Omega-3 Dosing: AHA Advisory 2019
The Skulas-Ray et al. AHA Science Advisory pooled data from over 17 randomized trials of prescription EPA, EPA + DHA, and combined preparations at 4 g/day for triglyceride lowering. [2] Across studies, this dose produced 20–30% reductions in fasting triglycerides; the effect was larger in patients with higher baseline triglycerides (about 30% reduction at baselines ≥500 mg/dL). The advisory explicitly noted that over-the-counter fish oil products are not interchangeable with prescription preparations because of variable EPA + DHA content, oxidation status, and dosing — and that the 4 g/day dose was effective and safe.
Outcome Trials of EPA: JELIS and REDUCE-IT
JELIS randomized 18,645 hypercholesterolemic Japanese patients to 1.8 g/day EPA plus low-dose statin or statin alone, with mean follow-up of 4.6 years. [5] Major coronary events occurred in 2.8% of the EPA group versus 3.5% of controls — a 19% relative risk reduction. The trial was open-label, conducted in a population with high baseline fish intake, and used pure EPA — features that limited generalizability but motivated the larger REDUCE-IT trial.
REDUCE-IT enrolled 8,179 statin-treated adults with triglycerides 135–500 mg/dL and either established cardiovascular disease or diabetes plus risk factors, randomized to 4 g/day icosapent ethyl (a stable, purified EPA ester) or mineral-oil placebo. [1] Over a median 4.9 years, the primary composite (cardiovascular death, MI, stroke, coronary revascularization, unstable angina) occurred in 17.2% of EPA-treated patients versus 22.0% of placebo — a 25% relative risk reduction (HR 0.75, 95% CI 0.68–0.83, p < 0.001). The benefit was larger than expected from triglyceride lowering alone, suggesting EPA also has direct anti-inflammatory and membrane-stabilizing effects on coronary plaque. Atrial fibrillation and bleeding were modestly more common with EPA, an important consideration in older patients. The negative STRENGTH trial of a different EPA + DHA preparation suggests that purified high-dose EPA, not omega-3 fatty acids generically, is what produced the REDUCE-IT result.
Niacin: Lipid Numbers Are Not Outcomes — AIM-HIGH
AIM-HIGH randomized 3,414 patients with established cardiovascular disease and atherogenic dyslipidemia (low HDL, high triglycerides) on simvastatin to extended-release niacin 1.5–2 g/day or placebo. [6] At two years, niacin had raised median HDL from 35 to 42 mg/dL, lowered triglycerides from 164 to 122 mg/dL, and lowered LDL from 74 to 62 mg/dL. Yet the primary composite endpoint occurred in 16.4% of niacin patients versus 16.2% of placebo — no benefit, with a small unexplained signal for ischemic stroke. The trial was stopped at three years for futility. The HPS2-THRIVE follow-up in 25,673 patients reached the same conclusion and added concerns about gastrointestinal bleeding, myopathy, and infection. AIM-HIGH and HPS2-THRIVE together explain why guidelines no longer recommend high-dose niacin for cardiovascular prevention — and serve as a reminder that surrogate-marker improvements do not always translate to clinical benefit.
Berberine: Dong 2013 Meta-Analysis
Dong and colleagues pooled 11 randomized controlled trials of berberine (alone or combined with lifestyle/standard therapy) in 874 participants with hyperlipidemia. [7] Berberine produced statistically significant mean differences of −0.50 mmol/L for triglycerides (about −44 mg/dL), −0.61 mmol/L for total cholesterol, −0.65 mmol/L for LDL cholesterol, and a non-significant trend toward higher HDL. The mechanism — upregulation of hepatic LDL receptors and AMPK activation — is well-characterized. The authors flagged methodological limitations (mostly Chinese trials, modest sample sizes, variable blinding) and called for larger Western trials, but the consistency of effect across studies and the dual benefit on glucose make berberine one of the better-evidenced botanical options for combined dyslipidemia and insulin resistance.
Exercise: Smart 2025 Meta-Analysis
Smart and colleagues' 2025 systematic review pooled 148 randomized controlled trials of exercise training in 8,673 adults, examining aerobic training, resistance training, and combined modalities for their effects on the full lipid panel. [8] Triglycerides fell by a weighted mean of 8.01 mg/dL (95% CI −10.45 to −5.58), a roughly 3.5–11.7% reduction depending on baseline. The effect was robust across exercise modalities, training durations of 8 weeks or longer, and supervised versus unsupervised programs. Total cholesterol and LDL cholesterol also improved modestly, while HDL rose. The triglyceride effect, while smaller per unit time than dietary changes, is independent of weight loss and additive to dietary improvements — meaning a person who trims sugar and walks 30 minutes a day captures both effects simultaneously.
Strength of Evidence: Summary
- Strongest: Cutting sugar-sweetened beverages, prescription EPA at 4 g/day, Mediterranean dietary pattern, regular aerobic exercise.
- Good: Berberine, oily fish 2–3 times per week, weight loss when above ideal weight, alcohol reduction.
- Mixed: Over-the-counter fish oil at standard 1 g/day doses (probably under-dosed for triglyceride benefit), niacin (lowers number but does not improve outcomes on top of statins).
- Practical priority: For most adults with triglycerides 150–400 mg/dL, the highest-leverage interventions are cutting liquid sugar, walking daily, eating fish twice a week, and adding 2–4 g/day of high-EPA omega-3. These are inexpensive, evidence-based, and tend to move the entire metabolic profile in the right direction simultaneously.
References
- Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaBhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM. New England Journal of Medicine, 2019. PubMed 30415628 →
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart AssociationSkulas-Ray AC, Wilson PWF, Harris WS, Brinton EA, Kris-Etherton PM, Richter CK, Jacobson TA, Engler MB, Miller M, Robinson JG, Blum CB, Rodriguez-Leyva D, de Ferranti SD, Welty FK. Circulation, 2019. PubMed 31422671 →
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humansStanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Journal of Clinical Investigation, 2009. PubMed 19381015 →
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or NutsEstruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Fito M, Gea A, Hernan MA, Martinez-Gonzalez MA. New England Journal of Medicine, 2018. PubMed 29897866 →
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysisYokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K. Lancet, 2007. PubMed 17398308 →
- Niacin in patients with low HDL cholesterol levels receiving intensive statin therapyBoden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. New England Journal of Medicine, 2011. PubMed 22085343 →
- The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trialsDong H, Zhao Y, Zhao L, Lu F. Planta Medica, 2013. PubMed 23512497 →
- The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysisSmart NA, Downes D, van der Touw T, Hada S, Dieberg G, Pearson MJ, Wolden M, King N, Goodman SPJ. Sports Medicine, 2025. PubMed 39331324 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.